AIMDAIMDTechnology · Scientific & Technical Instruments

AIMD Stock Forecast: Ainos, Inc. Price Predictions for 2026-2027

Last close, 8 Sept 2026
$1.48
−7.50% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 18 of 100 as at 8 Sept 2026 — in the weakest quartile.

Market cap
$11.8M
Ticker Nerd rank
18 / 100
Median analyst target
Analysts covering
0
Revenue$161.0−99.8% y/y
Operating income−$2.3M
Net income−$2.5M
Free cash flow−$992K
Quarterly, 7 quarters to 31 Mar 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+5.7%
1M
−0.7%
YTD
−9.8%
1Y
−59.0%
From 52W high
−65.2%
From 52W low
+14.7%
$1.29
$4.25
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

AIMD stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Ainos, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 8 Sept 2026
18 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Accruals
94
Size
92
Growth
50
Revisions
25
Momentum
20
Volatility
18
Quality
16
Issuance
6
Value
0

Accruals (94): Reported profit is backed by cash, and the company is not expanding recklessly.

Value (0): The shares cost a lot relative to the profits and assets behind them.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

AIMD stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on AIMD, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$1.00$1.50$2.00$2.50$3.00$3.50$4.00$4.50Oct 25Jan 26Apr 26Jul 26AIMD

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. AIMD appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

AIMD vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 8 Sept 2026, Ainos, Inc. returned −59.0% against +19.4% for the S&P 500, dividends included.

AIMD vs S&P 500, last 12 monthsTotal return, rebased to 100
406080100120Oct 25Jan 26Apr 26Jul 26AIMDS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

AIMD analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Ainos, Inc. (AIMD) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
−0.5×

Cheaper than 80% of US stocks

Price / sales
868.7×

Cheaper than 1% of US stocks

Price / book
3.6×

Cheaper than 29% of US stocks

EV / EBITDA
−2.7×

Cheaper than 73% of US stocks

Growth & margins
Revenue growth (YoY)
−96.7%

Higher than 2% of US stocks

Earnings growth (YoY)
−99.8%

Higher than 2% of US stocks

Gross margin
−373.9%

Higher than 1% of US stocks

Operating margin
−2894135.5%

Higher than 1% of US stocks

Net margin
82.9%

Higher than 99% of US stocks

Returns & dividend
Return on equity
−196.3%

Higher than 7% of US stocks

Return on assets
−39.6%

Higher than 10% of US stocks

Dividend yield

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Ainos, Inc. (AIMD) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Ainos, Inc. has a market value of $11.8M and an enterprise value of $24.2M.

  • Revenue in the twelve months to 31 Mar 2026: $18K. The latest quarter shrank 96.7% year on year.

  • Net income over the same four quarters: −$13.9M, a −76996.2% net margin.

  • Free cash flow in the twelve months to 31 Mar 2026: −$4.4M, after $8K of capital spending.

  • Shares outstanding: 7.4M.

  • Trailing P/E: −0.5×.

  • Ainos, Inc. employs 41 people $441.7 of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 31 Mar 2026 · market figures as at 8 Sept 2026

Data provided by Twelve Data

Peers

AIMD vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelScientific & Technical Instruments
CompanyMarket capTKN rank
AIMDAinos, Inc.$11.8M
18
ARAIArrive AI, Inc.$12.6M
7
ASTCAstrotech Corp.$15.3M
23
FCUVFocus Universal, Inc.$4.2M
18
MINDMIND Technology, Inc.$38.0M
16
SOBRSOBR Safe, Inc.$2.5M
23
ACFNAcorn Energy, Inc.$48.8M
33

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Ainos, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest AIMD news & analysis

Ainos Secures Three Japanese Robotics Patents, Advancing Chemical Perception for the Physical AI Era

Accesswire · 9 Sept 2026positive

Ainos announced it has been granted three new Japanese patents covering AI Nose technologies, including electronic nose integration with robotic systems, gas exchange, and rapid chemical detection. The patents expand the company's intellectual property portfolio to 124 patent assets worldwide, spanning chips, sensing architectures, chemical molecules, and real-world applications.

Why it matters — The new Japanese patents strengthen Ainos' intellectual property portfolio in the emerging field of Physical AI, potentially supporting its position in chemical perception technology for robotic and autonomous systems.

Ainos Launches Atmosphere Engine, Extending Physical AI from Environmental Sensing to Active Environmental Management

Accesswire · 19 Aug 2026positive

Ainos, Inc. announced the global launch of Atmosphere Engine, a new platform that extends its AI-powered environmental sensing and Chemical Intelligence capabilities into active environmental management by generating high-purity nitrogen and oxygen on-site from ambient air.

Why it matters — AIMD watchers would care because this platform expands the company's product scope beyond sensing into active environmental management for semiconductor manufacturing and AI infrastructure.

Ainos Unveils Next-Generation AI Nose, Advancing the Infrastructure for Chemical Intelligence

Accesswire · 17 Aug 2026positive

Ainos, Inc. announced the next generation of its AI Nose platform, featuring upgrades across software, firmware, edge computing, and industrial-grade hardware for continuous 24/7 real-world deployment. The company noted that over 878 million real-world smell data records support its Smell Intelligence foundation, with each AI Nose acting as a continuously learning node toward a broader Chemical Intelligence network.

Why it matters — AIMD watchers would care because this second-generation platform advances Ainos' transition from standalone smell sensing toward a distributed Chemical Intelligence infrastructure for Physical AI, strengthening the company's data foundation and deployment capabilities.

Ainos Surpasses 878 Million Real-World Data Points, Up 43% in 23 Days as 1,400-System AI Nose Semiconductor Deployment Advances

Accesswire · 13 Aug 2026positive

Ainos announced that its AI Nose platform has surpassed 878 million real-world smell and chemical data points, up from approximately 613 million reported on July 21, adding about 265 million data points in 23 days (roughly a 43% increase) as the AI Nose system deployment in semiconductor manufacturing environments advances.

Why it matters — AIMD watchers would care because the rapid expansion of the AI Nose dataset signals continued progress in the company's Real-World Data Flywheel and Chemical Intelligence development for Physical AI.

Ainos to Showcase Environmental Intelligence for Physical AI at SEMICON Taiwan 2026

Accesswire · 12 Aug 2026positive

Ainos, Inc. announced it will showcase its Environmental Intelligence solutions for Physical AI — including AI Nose and Atmosphere Engine — at SEMICON Taiwan 2026, scheduled for September 2-4.

Why it matters — The demonstration highlights Ainos' effort to apply its sensing technology to the emerging Physical AI market, potentially opening new commercial channels for its AI Nose and Atmosphere Engine platforms.

FAQ

Frequently asked questions about AIMD stock

How does Ticker Nerd's model rank AIMD?

As at 8 Sept 2026, Ainos, Inc. ranks 18 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Accruals (94 of 100).

What is the AIMD stock forecast for 2030?

No analyst covering Ainos, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for AIMD are extrapolating price history, which says nothing about the business.

How has AIMD stock performed over the past year?

Ainos, Inc. returned -59.0% over the 12 months to 8 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Ainos, Inc. do?

Ainos, Inc. is a dual-platform AI and biotechnology company focused on smelltech and immune therapeutics.

What is the latest news on AIMD?

The most recent item we track (Accesswire, 9 Sept 2026): "Ainos Secures Three Japanese Robotics Patents, Advancing Chemical Perception for the Physical AI Era". Ainos announced it has been granted three new Japanese patents covering AI Nose technologies, including electronic nose integration with robotic systems, gas exchange, and rapid chemical detection. The patents expand the company's intellectual property portfolio to 124 patent assets worldwide, spanning chips, sensing architectures, chemical molecules, and real-world applications.

Company

About Ainos, Inc.

Ainos, Inc. is a dual-platform AI and biotechnology company focused on smelltech and immune therapeutics. Ainos, Inc. develops AI Nose, an electronic olfaction platform that uses AI and a smell language model to convert scent and volatile compounds into machine-readable Smell ID data. This technology is used in applications such as robotics, smart factories, semiconductor manufacturing, healthcare, senior care, and women’s health. The company also develops VELDONA, a low-dose oral interferon platform designed for human and animal health applications, including rare, autoimmune, and infectious disease programs. In addition, Ainos, Inc. works on point-of-care testing and related diagnostic products, positioning itself at the intersection of digital sensing, medical technology, and therapeutic development.

CEO Mr. Chun-Hsien Tsai · 41 employees · United States · https://www.ainos.com